ASTRIS China: A Real-world Study of Osimertinib in Patients with EGFR T790M Positive Non-small-cell Lung Cancer (NSCLC)

Q. Zhou,H. -L. Zhang, L. -Y. Jiang,Y. -K. Shi,Y. Chen,J. -M. Yu,C. -C. Zhou, Y. He,Y. -P. Hu,Z. -A. Liang, Y. -Y. Pan, W. -L. Zhuo, Y. Song, G. Wu,G. -Y. Chen, Y. Lu,C. -Y. Zhang,Y. -P. Zhang,Y. Chen, S. Lu,Y. -L. Wu

JOURNAL OF THORACIC ONCOLOGY(2022)

Cited 1|Views5
No score
Key words
Non-small-cell lung cancer, Osimertinib, EGFR T790M-positive
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined